Robertson Stephens Wealth Management’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$288K Hold
11,133
– – 0.01% 524
2026
Q2
$351K Sell
11,133
-4,817
-30% -$109K 0.01% 493
2026
Q1
$110K Hold
15,950
– – ﹤0.01% 597
2025
Q4
$146K Hold
15,950
– – ﹤0.01% 614
2025
Q3
$344K Hold
15,950
– – 0.01% 423
2025
Q2
$326K Hold
15,950
– – 0.01% 440
2025
Q1
$436K Hold
15,950
– – 0.02% 386
2024
Q4
$522K Hold
15,950
– – 0.02% 352
2024
Q3
$362K Hold
15,950
– – 0.01% 492
2024
Q2
$593K Hold
15,950
– – 0.03% 306
2024
Q1
$904K Hold
15,950
– – 0.05% 248
2023
Q4
$1.26M Hold
15,950
– – 0.08% 199
2023
Q3
$1.1M Hold
15,950
– – 0.07% 195
2023
Q2
$1.75M Hold
15,950
– – 0.12% 142
2023
Q1
$1.71M Hold
15,950
– – 0.13% 142
2022
Q4
$1.36M Hold
15,950
– – 0.13% 148
2022
Q3
$1.07M Hold
15,950
– – 0.11% 147
2022
Q2
$1.19M Hold
15,950
– – 0.11% 144
2022
Q1
$2.34M Hold
15,950
– – 0.2% 97
2021
Q4
$5.41M Hold
15,950
– – 0.46% 47
2021
Q3
$6.97M Hold
15,950
– – 0.79% 29
2021
Q2
$5.57M Hold
15,950
– – 0.67% 33
2021
Q1
$5.84M Sell
15,950
-183
-1% -$75.3K 0.93% 24
2020
Q4
$6.05M Hold
16,133
– – 1.27% 19
2020
Q3
$7.28M Buy
+16,133
New +$9.3M 1.79% 14

Other funds holding CUE

Robertson Stephens Wealth Management's CUE Position: Q3 2026 in Review

Robertson Stephens Wealth Management held its Cue Biopharma (CUE) position steady in Q3 2026 at 11,133 shares worth $288K. The position accounts for 0.01% of the portfolio, ranked #524.

Robertson Stephens Wealth Management first reported a position in CUE in Q3 2020 and has held it in 25 quarters since. The position peaked at $7.28M in Q3 2020. 58 funds tracked by Wall St. Rank hold CUE as of Q3 2026.

  • Robertson Stephens Wealth Management held 11,133 shares of Cue Biopharma worth $288K as of Q3 2026.
  • Robertson Stephens Wealth Management left its Cue Biopharma share count unchanged in Q3 2026.
  • Cue Biopharma made up 0.01% of Robertson Stephens Wealth Management's portfolio in Q3 2026, its #524 holding.
  • Robertson Stephens Wealth Management first reported a position in Cue Biopharma in Q3 2020 and has held it in 25 quarters since.
  • Robertson Stephens Wealth Management's Cue Biopharma position peaked at $7.28M in Q3 2020.
  • 58 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.